Virus-host interactions encompass the complex relationship between viruses and their host organisms. These interactions are critical determinants of the outcome of viral infections, influencing factors such as host susceptibility, immune response, and the severity of disease. Upon entering a host, viruses interact with specific host cell receptors, facilitating attachment and entry. The host immune system recognizes and responds to viral infections through intricate signaling pathways, involving the activation of various immune cells and the release of antiviral molecules. Viruses, in turn, employ diverse strategies to evade or modulate host immune responses. This includes the inhibition of host antiviral proteins, interference with cellular signaling, and the ability to establish latent infections. Understanding virus-host interactions is essential for developing therapeutic interventions. Research in this field aims to uncover the molecular mechanisms governing these interactions, identify potential targets for antiviral drugs, and design strategies to modulate host immune responses for better outcomes. Ongoing studies in virology continue to deepen our understanding of virus-host interactions, contributing to the development of effective treatments and vaccines against viral infections.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom